Shares of GP-Act III Acquisition Corp. (NASDAQ:GPAT – Get Free Report) rose 0.2% on Thursday . The stock traded as high as $10.77 and last traded at $10.77. Approximately 36,652 shares were traded during trading, an increase of 126% from the average daily volume of 16,245 shares. The stock had previously closed at $10.75.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of GP-Act III Acquisition in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.
Check Out Our Latest Analysis on GPAT
GP-Act III Acquisition Stock Up 0.2%
GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last issued its quarterly earnings data on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter.
Institutional Investors Weigh In On GP-Act III Acquisition
Institutional investors and hedge funds have recently made changes to their positions in the stock. Longfellow Investment Management Co. LLC purchased a new stake in shares of GP-Act III Acquisition during the third quarter worth $83,000. Bank of America Corp DE acquired a new position in GP-Act III Acquisition during the 3rd quarter worth $85,000. Clear Street Group Inc. purchased a new stake in GP-Act III Acquisition during the 3rd quarter worth about $109,000. Clear Street LLC raised its position in GP-Act III Acquisition by 8,429.8% in the 2nd quarter. Clear Street LLC now owns 10,321 shares of the company’s stock valued at $109,000 after purchasing an additional 10,200 shares in the last quarter. Finally, Cannon Global Investment Management LLC acquired a new stake in GP-Act III Acquisition in the 3rd quarter valued at about $111,000.
GP-Act III Acquisition Company Profile
GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.
Recommended Stories
- Five stocks we like better than GP-Act III Acquisition
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
